← Back to all trials
Not Yet Recruiting
NCT05719155
Pharmacokinetics and Safety/Tolerability of CKD-379
Conditions: Type II Diabetes Mellitus
Sex: All
Ages: 19 Years – 50 Years
Healthy volunteers: 1
Phase: PHASE1
Enrollment: 32
Sponsor: Chong Kun Dang Pharmaceutical
Summary
A study to compare the pharmacokinetics and safety/tolerability between CKD-379 tablet and D759, D745, D150 combination
Eligibility Criteria
Inclusion Criteria:Between 19 aged and 50 aged in healthy adult50.0kg≤Body weight≤90.0kg
and 18.0kg/m2≤body mass index(BMI)≤27.0kg/m2Exclusion Criteria:Have clinical significant medical history or disease that hepatobiliary system, kidney, nervous system, immune system, respiratory system, digestive system, urinary system, endocrine system(Type I or Type II Diabetes Mellitus, diabetic ketoacidosis etc.), hematological system, cardiovascular system(heart failure, Torsades de pointes etc.), mental illnessHave clinical significant medical history or disease that urinary tract infection or genital infection including urosepsis, pyelonephritisHave a gastrointestinal disease(Crohn's disease, ulcer etc.) history that can effect drug absorption or surgeryThose who are pregnant or breastfeedingThose who are deemed inappropriate to participate in clinical trial by investigators
Source: ClinicalTrials.gov (NCT05719155). StuddyBuddy aggregates publicly available trial information.
